We are live on
!
Find out more
TI
Turner Investments Portfolio holdings
AUM
$134K
1-Year Est. Return
49.03%
This Fund
S&P 500
This Quarter
Est. Return
+10.67%
1 Year Est. Return
-49.03%
3 Year Est. Return
+6.36%
5 Year Est. Return
+75.79%
10 Year Est. Return
–
AUM
$547M
AUM Growth
-$9.74M
(-1.8%)
Cap. Flow
-$42M
Cap. Flow
% of AUM
-7.68%
Top 10 Holdings %
Top 10 Hldgs %
16.06%
Holding
480
New
78
Increased
86
Reduced
74
Closed
239
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VF Corp
VFC
|
+$5.76M |
| 2 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$5.22M |
| 3 |
Cencora
COR
|
+$4.35M |
| 4 |
Netflix
NFLX
|
+$4.25M |
| 5 |
Starbucks
SBUX
|
+$3.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$5.47M |
| 2 |
Hershey
HSY
|
+$3.86M |
| 3 |
Ambarella
AMBA
|
+$3.62M |
| 4 |
Sprouts Farmers Market
SFM
|
+$3.42M |
| 5 |
PTC Therapeutics
PTCT
|
+$3.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.46% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 10.94% |
| 4 | Financials | 9.21% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Gray Television
GTN
$441M
| $1.44M | 0.26% |
+91,860
| New | +$1.35M |
|
|
ESPR
127
DELISTED
Esperion Therapeutics
ESPR
| $1.44M | 0.26% |
+17,560
| New | +$1.72M |
|
128
Constellation Brands
STZ
$22.4B
| $1.43M | 0.26% |
12,310
+8,370
| +212% | +$988K |
|
129
Applied Materials
AMAT
$434B
| $1.42M | 0.26% |
73,720
-128,410
| -64% | -$2.64M |
|
130
Burlington
BURL
$23.2B
| $1.4M | 0.26% |
27,380
+12,550
| +85% | +$671K |
|
|
RCPT
131
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $1.39M | 0.25% |
7,330
-16,670
| -69% | -$2.75M |
|
|
HW
132
DELISTED
Headwaters Inc
HW
| $1.38M | 0.25% |
75,610
-42,640
| -36% | -$807K |
|
|
SYNH
133
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.37M | 0.25% |
+34,140
| New | +$1.18M |
|
134
CONMED
CNMD
$1.51B
| $1.36M | 0.25% |
+23,390
| New | +$1.26M |
|
|
KYTH
135
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $1.36M | 0.25% |
+18,020
| New | +$966K |
|
136
Aptiv
APTV
$10.1B
| $1.34M | 0.25% |
+15,800
| New | +$1.35M |
|
|
NBSE
137
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $1.34M | 0.25% |
1,338
+622
| +87% | +$671K |
|
138
RH
RH
$3.56B
| $1.29M | 0.24% |
13,260
+5,320
| +67% | +$491K |
|
139
Euronet Worldwide
EEFT
$2.93B
| $1.29M | 0.24% |
+20,950
| New | +$1.25M |
|
140
OneSpan
OSPN
$601M
| $1.28M | 0.23% |
+42,380
| New | +$1.15M |
|
|
TBI
141
Trueblue
TBI
$234M
| $1.26M | 0.23% |
+42,080
| New | +$1.19M |
|
142
Guidewire Software
GWRE
$13.3B
| $1.25M | 0.23% |
23,650
-2,140
| -8% | -$110K |
|
|
PVTB
143
DELISTED
PrivateBancorp Inc
PVTB
| $1.25M | 0.23% |
31,260
-6,870
| -18% | -$262K |
|
|
PN
144
DELISTED
Patriot National, Inc.
PN
| $1.24M | 0.23% |
+77,420
| New | +$1.18M |
|
|
BSFT
145
DELISTED
BroadSoft, Inc.
BSFT
| $1.22M | 0.22% |
35,360
+5,360
| +18% | +$190K |
|
146
IMAX
IMAX
$2.81B
| $1.19M | 0.22% |
29,645
+11,880
| +67% | +$461K |
|
147
CME Group
CME
$94.4B
| $1.19M | 0.22% |
12,800
+8,260
| +182% | +$771K |
|
148
Amazon
AMZN
$2.99T
| $1.19M | 0.22% |
54,800
+25,200
| +85% | +$527K |
|
149
Nike
NKE
$61.6B
| $1.19M | 0.22% |
22,000
-8,260
| -27% | -$423K |
|
|
CPRX
150
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.18M | 0.22% |
+286,370
| New | +$1.14M |
|
Similar funds
IP
DVC
PAM
CCM
GA
IPLA
LRM
HC
Turner Investments's Q2 2015 Portfolio in Review
As of Q2 2015, Turner Investments held 480 positions worth $547M, down 1.8% from $556M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Turner Investments withdrew a net $42M in Q2 2015, closing 239 positions and reducing 74 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $5.47M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Turner Investments opened a new position in VF Corp worth $5.6M.
- Turner Investments's largest Q2 2015 buy was VF Corp: 85,226 shares worth $5.6M.
- Turner Investments added most to Cencora in Q2 2015, an estimated $4.35M increase.
- Turner Investments's biggest Q2 2015 reduction was Ambarella, cutting an estimated $3.62M.
- Turner Investments fully exited Alexion Pharmaceuticals in Q2 2015, selling an estimated $5.47M.
- Turner Investments's ten largest holdings make up 16% of its $547M portfolio in Q2 2015.
- Turner Investments opened 78 new positions and closed 239 in Q2 2015.
- Turner Investments's portfolio value fell 1.8% quarter-over-quarter to $547M.
Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.